New ETF Recommendations
The AlphaProfit ETF style rotation model portfolio will be reconstituted with new recommendations on Monday, November 20. Learn more about AlphaProfit's Free and Premium Service investment newsletters.
“In the investing blog, I seek to help you take sound investment decisions free from emotion by sharing my objective insights on markets, sectors, and companies.”
Led by large-cap technology stocks, the S&P 500 set new records last week despite the Fed’s concerns on economic recovery and mixed economic data.
Helped by the steadying COVID-19 case count, stocks sensitive to the ‘reopening’ of the economy rose despite mixed economic data and stalemate on stimulus.
Strong economic data and slowing COVID-19 infections helped stocks to rally broadly despite Washington’s failure on stimulus.
Strong earnings and comforting comments from the Fed helped stocks maintain their uptrend despite weak economic data and a divisive Congress.
Stocks were virtually unchanged last week after jobless claims data and faltering Sino-U.S. relations offset promising COVID-19 vaccine trial results.
Gains in stock prices from progress on COVID-19 vaccines were limited by mixed economic data and the continued rise in COVID-19 cases.
As COVID-19 cases continued to surge, investors sought safety in large-cap technology stocks and pushed the NASDAQ Composite Index to new all-time highs.
Stocks rose as better-than-expected economic data and positive news on an experimental COVID-19 vaccine calmed fears from rising number of COVID-19 cases.
Fears of economic damage from COVID-19 increased. The Fed restricted banks from returning capital to shareholders. Stocks closed near their two-week low.
Stocks reacted positively to retail sales data and the Federal Reserve’s decision to buy corporate bond. The rising COVID-19 case count limited the gains.
THE GOOD NEWS JUST BEGINS!